Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Cryobiology ; 92: 215-230, 2020 02 01.
Article in English | MEDLINE | ID: mdl-31972153

ABSTRACT

Through enabling an efficient supply of cells and tissues in the health sector on demand, cryopreservation is increasingly becoming one of the mainstream technologies in rapid translation and commercialization of regenerative medicine research. Cryopreservation of tissue-engineered constructs (TECs) is an emerging trend that requires the development of practically competitive biobanking technologies. In our previous studies, we demonstrated that conventional slow-freezing using dimethyl sulfoxide (Me2SO) does not provide sufficient protection of mesenchymal stromal cells (MSCs) frozen in 3D collagen-hydroxyapatite scaffolds. After simple modifications to a cryopreservation protocol, we report on significantly improved cryopreservation of TECs. Porous 3D scaffolds were fabricated using freeze-drying of a mineralized collagen suspension and following chemical crosslinking. Amnion-derived MSCs from common marmoset monkey Callithrix jacchus were seeded onto scaffolds in static conditions. Cell-seeded scaffolds were subjected to 24 h pre-treatment with 100 mM sucrose and slow freezing in 10% Me2SO/20% FBS alone or supplemented with 300 mM sucrose. Scaffolds were frozen 'in air' and thawed using a two-step procedure. Diverse analytical methods were used for the interpretation of cryopreservation outcome for both cell-seeded and cell-free scaffolds. In both groups, cells exhibited their typical shape and well-preserved cell-cell and cell-matrix contacts after thawing. Moreover, viability test 24 h post-thaw demonstrated that application of sucrose in the cryoprotective solution preserves a significantly greater portion of sucrose-pretreated cells (more than 80%) in comparison to Me2SO alone (60%). No differences in overall protein structure and porosity of frozen scaffolds were revealed whereas their compressive stress was lower than in the control group. In conclusion, this approach holds promise for the cryopreservation of 'ready-to-use' TECs.


Subject(s)
Collagen/pharmacology , Cryopreservation/methods , Cryoprotective Agents/pharmacology , Durapatite/pharmacology , Mesenchymal Stem Cells/cytology , Animals , Biological Specimen Banks , Callithrix , Cell Survival/drug effects , Dimethyl Sulfoxide/pharmacology , Freezing , Sucrose/pharmacology , Tissue Engineering
2.
Biofactors ; 42(3): 287-95, 2016 May.
Article in English | MEDLINE | ID: mdl-26948854

ABSTRACT

The effects of bioregulators of stem and progenitor cells (BSPC) of fetal tissue cytosol on rat liver during 24h hypothermic storage (HS) and following normothermic reperfusion (NR) were investigated. It was shown that BSPC presence in the preservation medium stabilized pro-oxidant-antioxidant balance impaired in liver after HS and NR, prevented the uncoupling of mitochondrial oxidative phosphorylation and ATP level decline. These consequences led to significant improvement of hepatic morphological integrity and functional state. Powerful protective effect of BSPC on liver at sub-zero temperatures can serve as basis for new approaches to extend safe time for organ preservation and foster understanding of pathways of stem and progenitor cell paracrine action. © 2016 BioFactors, 42(3):287-295, 2016.


Subject(s)
Liver/metabolism , Reperfusion Injury/metabolism , Specimen Handling , Stem Cells/metabolism , Adenosine Triphosphate/metabolism , Animals , Antioxidants/pharmacology , Cold Temperature , Culture Media/pharmacology , Humans , Liver/drug effects , Liver/physiopathology , Paracrine Communication/drug effects , Rats , Reactive Oxygen Species/pharmacology , Reperfusion Injury/physiopathology , Reperfusion Injury/prevention & control , Stem Cells/cytology
3.
J Mater Sci Mater Med ; 25(3): 857-71, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24297514

ABSTRACT

Cultivation and proliferation of stem cells in three-dimensional (3-D) scaffolds is a promising strategy for regenerative medicine. Mesenchymal stem cells with their potential to differentiate in various cell types, cryopreserved adhesion-based in fabricated scaffolds of biocompatible materials can serve as ready-to-use transplantation units for tissue repair, where pores allow a direct contact of graft cells and recipient tissue without further preparation. A successful cryopreservation of adherent cells depends on attachment and spreading processes that start directly after cell seeding. Here, we analyzed different cultivation times (0.5, 2, 24 h) prior to adhesion-based cryopreservation of human mesenchymal stem cells within alginate-gelatin cryogel scaffolds and its influence on cell viability, recovery and functionality at recovery times (0, 24, 48 h) in comparison to non-frozen control. Analysis with confocal laser scanning microscopy and scanning electron microscopy indicated that 2 h cultivation time enhanced cryopreservation success: cell number, visual cell contacts, membrane integrity, motility, as well as spreading were comparable to control. In contrast, cell number by short cultivation time (0.5 h) reduced dramatically after thawing and expanded cultivation time (24 h) decreased cell viability. Our results provide necessary information to enhance the production and to store ready-to-use transplantation units for application in bone, cartilage or skin regenerative therapy.


Subject(s)
Batch Cell Culture Techniques/instrumentation , Cryopreservation/methods , Guided Tissue Regeneration/instrumentation , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/physiology , Tissue Engineering/instrumentation , Tissue Scaffolds , Alginates/chemistry , Batch Cell Culture Techniques/methods , Cell Adhesion/physiology , Cell Culture Techniques/instrumentation , Cells, Cultured , Cryogels/chemistry , Equipment Design , Equipment Failure Analysis , Gelatin/chemistry , Glucuronic Acid/chemistry , Hexuronic Acids/chemistry , Humans , Regenerative Medicine/instrumentation
4.
Cryobiology ; 55(1): 72-9, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17624324

ABSTRACT

The liver plays a central role in lipid metabolism and the pathophysiology of many lipid disorders leads in turn to liver cell injury. Adult hepatocyte transplants provide well-recognized metabolic support, whilst hepatic stem cells may promote liver regeneration and repair, but in both cases, any clinical application would require low temperature banking of the cells. A model of dietary hypercholesterolemia was established in rabbits over 5 months, and transplants of cryopreserved adult hepatocytes (CH) and cryopreserved fetal liver cells (CFLC) were compared to Sham transplants. Cryopreservation was performed by a two-step freezing protocol using 1.5mol/l dimethyl sulfoxide (Me(2)SO). Serum contents of cholesterol lipid classes were measured during the subsequent 4 weeks, in addition to markers of serum and liver oxidative stress. Both CH and CFLC transplantation resulted in a decrease of serum lipids during the 1st week after transplantation. The effect of CH was limited to the 1st week, but CFLC provided a sustained lipid-lowering effect over the 4 weeks. The ultimate outcome of CFLC transplantation by the end of 4 weeks was more pronounced and statistically significant for both serum total cholesterol (0.15+/-0.05 versus 3.65+/-1.4mmol/l) and high-density lipoprotein-cholesterol (0.04+/-0.01 versus 0.56+/-0.06mmol/l) compared to Sham transplants (p<0.05 in both cases). CFLC transplantation also normalized hepatic tissue antioxidant defenses, namely an increase in reduced glutathione content, and enzyme activities for catalase and glutathione reductase (all significantly higher at p<0.05 than in Sham transplants) by 4 weeks.


Subject(s)
Cryopreservation , Fetal Tissue Transplantation , Hepatocytes/transplantation , Hypercholesterolemia/therapy , Liver/enzymology , Animals , Antioxidants/metabolism , Cell Separation , Hypercholesterolemia/metabolism , Hypercholesterolemia/pathology , Lipid Peroxidation/physiology , Lipids/blood , Liver/metabolism , Liver/pathology , Rabbits
5.
Cell Transplant ; 15(1): 23-33, 2006.
Article in English | MEDLINE | ID: mdl-16700327

ABSTRACT

Hepatocyte transplantation is a promising method for supporting hepatic function in a broad spectrum of liver diseases. The aim of this work was to test the efficacy of human fetal liver cells to support the chronic failing liver in an experimental model of carbon tetrachloride (CCl4)-induced cirrhosis in rats. Liver cirrhosis was induced by intraperitoneal administration of CCl4 at a dose of 0.2 ml (50% v/v solution)/100 g body weight, twice a week for 3 months in rats. Ten days after stopping CCl4 administration (experimental day 0), rats received intrasplenic injection of cryopreserved fetal liver cells (FLC, 1 x 10(7) cells in 0.3 ml medium). As a cirrhotic control group, CCl4-induced cirrhotic rats were used with intrasplenic injection of an equal volume of medium alone. Animals were sacrificed on experimental day 15. Human fetal liver cell transplantation almost completely prevented the death of cirrhotic animals during the 2 weeks after treatment, while high ongoing mortality was seen in the cirrhotic control group. Cell transplantation into the spleen normalized total bilirubin and TBARSs levels and increased albumin levels in blood serum, as well as restoring mitochondrial function and liver detoxification function (assessed by cytochrome P450 contents and activity) compared with the activities seen in the cirrhosis control group. In parallel with this restoration of biochemical and functional liver indices, morphological patterns of liver recovery or regeneration after liver cell transplantation were demonstrated in day 15 samples by light microscopy. These were absent in the group that had received only medium alone.


Subject(s)
Fetal Tissue Transplantation , Hepatocytes/transplantation , Liver Cirrhosis/therapy , Liver Failure/therapy , Animals , Carbon Tetrachloride , Chronic Disease , Cryopreservation , Cytochrome P-450 Enzyme System/metabolism , Disease Models, Animal , Fetus , Humans , Liver/metabolism , Liver/pathology , Liver Cirrhosis/chemically induced , Liver Cirrhosis/pathology , Liver Failure/chemically induced , Liver Failure/pathology , Liver Function Tests , Male , Mitochondria/metabolism , Mixed Function Oxygenases/metabolism , Rats , Rats, Wistar , Survival Rate , Transplantation, Heterologous
SELECTION OF CITATIONS
SEARCH DETAIL
...